Machine learning for better medicines

Presented by Daphne Koller, insitro
Moderated by Jose-Carlos Gutiérrez-Ramos, Danaher
insitro is revolutionizing target and drug discovery by integrating multimodal data from human cohorts and cellular models with AI and machine learning to uncover genetic targets for complex diseases. Their approach, grounded in human genetics andfocused on metabolic disease, neurodegeneration, and oncology, aims to increase the probability of success and optimize clinical trials by targeting patients who can benefit the most.